Our mission is to become a worldwide reference for education in the field for all professionals involved in the process to dissemintate knowledge & skills of Acute Cardiovascular Care
Our mission is to promote excellence in clinical diagnosis, research, technical development, and education in cardiovascular imaging in Europe.
Our goal is to reduce the burden in cardiovascular disease in Europe through percutaneous cardiovascular interventions.
Promoting excellence in research, practice, education and policy in cardiovascular health, primary and secondary prevention.
Our Mission is "to improve the quality of life of the population by reducing the impact of cardiac rhythm disturbances and reduce sudden cardiac death"
To improve quality of life and logevity, through better prevention, diagnosis and treatment of heart failure, including the establishment of networks for its management, education and research.
Working Groups goals is to stimulate and disseminate scientific knowledge in different fields of cardiology.
ESC Councils goal is to share knowledge among medical professionals practising in specific cardiology domains.
OUR MISSION: TO REDUCE THE BURDEN OF CARDIOVASCULAR DISEASE
Prof. Mark John Monaghan,
View the Slides from this session in ESC Congress 365
3D Echocardiography has been widely discussed as a technique to assess the left ventricle and the left side heart valves. In this session, Chaired by myself (Prof. Mark Monaghan) and Prof. Manni Vannan (Atlanta, US) it was refreshing to hear 4 expert presenters focus on the applications of 3D in the right heart.
Dr. Fausto Rigo started the session with an excellent presentation on right atrial anatomy and function which was superbly illustrated with high-quality 3D images demonstrating excellent correlation between true anatomy and 3D images. Dr Rigo explained the important anatomical features relevant for structural interventions and EP and he highlighted the need to display images in a way that would be familiar to Interventional Cardiologists and Electrophysiologists who are used to looking at Fluoro images.
Dr. Moya Mur presented next on the tricuspid valve and he explained how inadequately this structure is seen on 2D Echo. The added value of 3D Echo in evaluating a range of tricuspid valve pathologies, including carcinoid was very well demonstrated. In addition, he highlighted the important role that 3D Echo can play in identifying the mechanism of tricuspid regurgitant in patients with pacing wire induced TR. This is not infrequent and it appears that 3D Echo can nicely demonstrate how the position of the wire across the tricuspid valve can cause regurgitation.
Prof. Partho Segupta (New York, US) gave the next presentation on assessing the normal right ventricle. This talk was outstanding and he elegantly explained the different anatomical features of the RV, how they all contribute to RV function and the strengths and weaknesses of 3D in assessing this chamber. He brought home the message that 2D and 3D Echo are really complementary in this context. His presentation generated a lot of interest and many questions from the audience.
The last presentation was given by Prof. Petros Nihoyannopoulos from Imperial College. He has published extensively on the role of Echo in assessing RV dysfunction so it seemed entirely appropriate that he should deliver this talk on using 3D. He gave fascinating insight into how 3D speckle tracking, may in the future, be used to clinically assess the RV, in the same way as it is currently used in the LV. This generated a stimulating discussion about the merits of including the ventricular septum in strain analysis of the RV and how the concept of ventricular interdependence influences the functional parameters we are using.
All in all, this was a well attended session which generated a lot of discussion, questions from the audience and very positive feedback. The general consensus was that we want more sessions in the future on 3D Echo and the right heart.
SessionTitle: 3D echocardiography: an innovation to assess right heart?